Kibo Energy PLC

M&A Activity • Aug 4, 2023

National Storage Mechanism | Additional information

RNS Number : 2720I

Kibo Energy PLC

04 August 2023

Kibo Energy PLC (Incorporated in Ireland)

(Registration Number: 451931)

(External registration number: 2011/007371/10)

LEI Code: 635400WTCRIZB6TVGZ23

Share code on the JSE Limited: KBO

Share code on the AIM: KIBO

ISIN: IE00B97C0C31

('Kibo' or 'the Company')

Dated: 4 August 2023

Kibo Energy PLC ('Kibo' or the 'Company')

Kibo Subsidiary Announces Update on Completion of Joint Venture

Kibo Energy PLC (AIM: KIBO; AltX: KBO), the renewable energy-focused development company, announces today that its subsidiary Mast Energy Developments ('MED'), a UK-based multi-asset operator in the rapidly growing flexible power market, has extended the completion long-stop date for its first definitive and binding Joint Venture Agreement ('JVA'), as announced on 12 July 2023, on account of exceptional circumstances as detailed below.

MED is currently working with the investor consortium to finalise the necessary logistical and statutory arrangements to ensure the completion and transfer of funds in accordance with the revised long-stop date as well as finalise terms for the second joint venture, which as previously announced, would increase the total investment value to c. £31m.

Further details can be found in the full announcement, which can be viewed at med.energy. The full text of the MED RNS follows:

-------------------------------------------

Dated: 4 August 2023

Mast Energy Developments PLC ('MED' or 'the Company')

MED Binding Joint Venture Completion Update

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcement dated 12 July 2023, it has extended the completion long-stop date for the first definitive and binding Joint Venture Agreement ('JVA') on account of exceptional circumstances. The revised completion date is now expected around 31 August 2023. The extension is due to the principal of Seira Capital, MED's JV lead investor partner being involved in a tragic road accident in which he was seriously injured and remaining hospitalised and in critical condition. MED is currently working with the JV investor consortium to expedite the transfer of the JVA investment funds and to complete the transaction without any further undue delay. In this regard, the Company has received the full co-operation of the investor consortium and has already reached agreement on how the revised completion long-stop date can be met. The parties are now working on finalising the necessary logistical and statutory arrangements to ensure successful completion and transfer of funds in accordance with the revised long-stop date.

Further, the JVA also commits both parties, as set out in MED's announcement dated 12 July 2023, to promptly finalise terms on a second joint venture that will increase the envisaged total investment value to c. £31m, with a total portfolio of low-carbon flexible gas generation peaker plants totally a combined generation output of up to c. 33 MW, to be developed and/or acquired, constructed and in production and income-generating under the two joint ventures ('Secondary JVA'). MED has now received the published guidance from the FCA and the FCA have confirmed that they agree with MED that entrance into the second joint venture would not constitute a reverse takeover. As such, notwithstanding the extension of completion of the first JVA as referred to above, MED will endeavour to finalise terms for the second JV promptly.

Pieter Krügel, CEO of MED, commented: "We wish our JV investor partner principal and his family all the best during this challenging time. We are pleased to receive support from the JV investor consortium in the meantime, and we are confident that we will be able to complete the transaction shortly.

"Further, we are pleased to have received the clearance from the FCA regarding the Secondary JVA, and we are looking forward to finalising the second JVA promptly and will update the market on both matters in due course."

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please visit www.med.energy or contact:

Pieter Krügel	Info@med.energy	Mast Energy Developments PLC	CEO
Jon Belliss	+44 (0)20 7399 9425	Novum Securities	Corporate Broker
Zainab Slemang van Rijmenant	zainab@lifacommunications.com	Lifa Communications	Investor & Media Relations Advisor

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014.

**ENDS**

For further information please visit www.kibo.energy or contact:

Louis Coetzee	info@kibo.energy	Kibo Energy PLC	Chief Executive Officer
James Biddle Roland Cormish	+44 207 628 3396	Beaumont Cornish Limited	Nominated Adviser
Claire Noyce	+44 20 3764 2341	Hybridan LLP	Joint Broker
Damon Heath	+44 207 186 9952	Shard Capital Partners LLP	Joint Broker
Zainab Slemang van Rijmenant	zainab@lifacommunications.com	Lifa Communications	Investor and Media Relations Consultant

Johannesburg

04 August 2023

Corporate and Designated Adviser

River Group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDFLFEETRIVIIV